Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys - Pestana, J O; Grinyo, J M; Vanrenterghem, Y (Am J Transplant, 2012)
et al.